tauroglycocholic acid has been researched along with etoposide in 1 studies
| Studies (tauroglycocholic acid) | Trials (tauroglycocholic acid) | Recent Studies (post-2010) (tauroglycocholic acid) | Studies (etoposide) | Trials (etoposide) | Recent Studies (post-2010) (etoposide) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 18,306 | 3,693 | 4,900 |
| Protein | Taxonomy | tauroglycocholic acid (IC50) | etoposide (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | 1.153 | |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 1.4284 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.187 | |
| Caspase-3 | Homo sapiens (human) | 1 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 0.4299 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, PI; Joel, SP; Slevin, ML | 1 |
1 other study(ies) available for tauroglycocholic acid and etoposide
| Article | Year |
|---|---|
Stability of the i.v. and oral formulations of etoposide in solution.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Drug Stability; Ethanol; Etoposide; Hydrogen-Ion Concentration; Injections, Intravenous; Solutions; Taurocholic Acid | 1995 |